I indikationen ” øge udbyttet af autologt blod ”: myokardieinfarkt eller apopleksi i månederne forud for behandlingen, ustabil angina pectoris, øget risiko for dyb venetrombose som anamnese med venøse tromboembolisk sygdom.
In the indication “ increasing the yield of autologous blood”: myocardial infarction or stroke in the month preceding treatment, unstable angina pectoris, increased risk of deep venous thrombosis such as history of venous thromboembolic disease.